269f0768 2e6c 4188 Ba86 2d7420d31a21 01
Chemical structure of Rizatriptan Benzoate, showing its molecular components and connections.*
Rizatriptan Benzoate Tablet, Orally Disintegrating
Product Images NDC 29300-268
10 FDA label images from Unichem Pharmaceuticals (usa), Inc. · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rizatriptan Benzoate (NDC 29300-268). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Unichem Pharmaceuticals (usa), Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
269f0768 2e6c 4188 Ba86 2d7420d31a21 02
A line graph showing the estimated probability of response over time (hours post-dose) for Rizatriptan Benzoate Tablets, USP 5 mg, 10 mg, and placebo. The x-axis represents hours post-dose from 0 to 2, and the y-axis shows estimated probability of response as a percentage from 0% to 100%. Three lines with different markers represent placebo (square), 5 mg (triangle), and 10 mg (inverted triangle) doses, with both doses showing higher response probabilities than placebo over time.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 03
A line graph depicting the estimated probability of remediation or rescue over 24 hours post-dose for Rizatriptan Benzoate Tablets, USP 5 mg and 10 mg, compared to placebo. The graph shows three lines representing placebo, 5 mg, and 10 mg doses, with probability percentages on the y-axis and hours post-dose on the x-axis.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 04
A line graph depicting the estimated probability of response over 2 hours post-dose for Rizatriptan Benzoate Orally Disintegrating Tablets at 5 mg and 10 mg doses compared to placebo. The x-axis represents hours post-dose (0 to 2), and the y-axis shows the estimated probability of response (%) from 0% to 100%. The 10 mg dose shows the highest response probability, followed by the 5 mg dose, with placebo the lowest.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 05
A line graph showing the estimated probability of remediation or rescue over 24 hours post-dose for Rizatriptan Benzoate Orally Disintegrating Tablets USP at 5 mg and 10 mg strengths compared to placebo. The x-axis indicates hours post-dose (0 to 24), and the y-axis shows the probability percentage (0% to 100%). Three lines represent placebo, 5 mg dose, and 10 mg dose, each with distinct dash styles.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 06
A line graph comparing Rizatriptan Benzoate Orally Disintegrating Tablets, USP to placebo. The x-axis shows Hours Post Stage 2 Dose (0.5 to 2.0 hours) and the y-axis shows Percent (95% CI) from 0 to 100. The graph shows increasing percent values over time for both Rizatriptan Benzoate and placebo, with Rizatriptan Benzoate consistently higher throughout the time points.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 07
269f0768 2e6c 4188 Ba86 2d7420d31a21 08
269f0768 2e6c 4188 Ba86 2d7420d31a21 09
Packaging label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP, 5 mg. The label indicates the product is an oral disintegrating tablet with a strength of 5 mg. It is labeled for prescription use only and manufactured by Unichem Pharmaceuticals (USA), Inc. The label also includes instructions to dispense with patient information, package details, and storage warnings.*
269f0768 2e6c 4188 Ba86 2d7420d31a21 10
Box label for Rizatriptan Benzoate Orally Disintegrating Tablets, USP, 10 mg strength. The label indicates the package contains 18 orally disintegrating tablets in 6 blister strips of 3 tablets each. It is labeled for prescription use only and manufactured by Unichem Pharmaceuticals (USA), Inc. The label includes storage instructions, barcode, and warning to keep out of reach of children.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
